| 000 | 01277 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513104834.0 | ||
| 264 | 0 | _c19970226 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0195-6108 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKnauth, M | |
| 245 | 0 | 0 |
_aMR enhancement of brain lesions: increased contrast dose compared with magnetization transfer. _h[electronic resource] |
| 260 |
_bAJNR. American journal of neuroradiology _c |
||
| 300 |
_a1853-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aContrast Media _xadministration & dosage |
| 650 | 0 | 4 | _aGadolinium |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImage Enhancement _xmethods |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xadministration & dosage |
| 700 | 1 | _aForsting, M | |
| 700 | 1 | _aHartmann, M | |
| 700 | 1 | _aHeiland, S | |
| 700 | 1 | _aBalzer, T | |
| 700 | 1 | _aSartor, K | |
| 773 | 0 |
_tAJNR. American journal of neuroradiology _gvol. 17 _gno. 10 _gp. 1853-9 |
|
| 999 |
_c8926279 _d8926279 |
||